Aripiprazole Lauroxil

Overview

Aripiprazole Lauroxil is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2219425).

API suppliers (4)

Suppliers of Aripiprazole Lauroxil evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• ZAKLADY FARMACEUTYCZNE POLPHARMA SA1 active DMF
• MSN PHARMACHEM PRIVATE LTDIndia1 active DMF
• Neuland Laboratories LimitedIndia1 active DMF
• INTERQUIM SAPeru1 active DMF GMP on record

Patent & exclusivity (US)

Per the FDA Orange Book (5 approved US products), the latest listed US patent on Aripiprazole Lauroxil expires 6 Apr 2039. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

[7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-2-oxo-3,4-dihydroquinolin-1-yl]methyl dodecanoate

Canonical SMILES

CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=C1C=C(C=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl

InChIKey

DDINXHAORAAYAD-UHFFFAOYSA-N